Pathophysiology of Calcium Mediated Ventricular Arrhythmias and Novel Therapeutic Options with Focus on Gene Therapy

Area of Science:

• Cardiology
• Molecular Biology
• Genetics

Background:

• Cardiac arrhythmias pose significant health risks and economic burdens.
• Incomplete understanding of arrhythmogenesis molecular mechanisms hinders effective treatment.
• Calcium (Ca²⁺) handling is critical for cardiac function and a potential target for arrhythmia therapies.

Purpose of the Study:

• To elucidate the role of Ca²⁺-handling in congenital and acquired ventricular arrhythmias.
• To explore the therapeutic potential of gene therapy for arrhythmia treatment.
• To identify cellular and mitochondrial targets for gene transfer in arrhythmia therapy.

Main Methods:

• Review of current research on Ca²⁺-handling in cardiac electrophysiology.
• Analysis of molecular mechanisms underlying ventricular arrhythmias.
• Investigation of gene therapy strategies for targeting Ca²⁺-handling proteins.

Main Results:

• Ca²⁺-handling dysfunction is implicated in various ventricular arrhythmia syndromes.
• Gene therapy presents a novel approach for modulating Ca²⁺-handling and suppressing arrhythmias.
• Specific cellular and mitochondrial targets show promise for therapeutic gene transfer.

Conclusions:

• Dysfunctional Ca²⁺-handling is central to ventricular arrhythmias.
• Gene therapy offers a promising avenue for future arrhythmia treatments.
• Targeting cellular and mitochondrial components via gene transfer warrants further investigation.